James Ehrlich, MD, is a physician specializing in internal medicine and general nephrology, with a career spanning clinical care, preventive cardiometabolic medicine, and advanced cardiovascular imaging. He currently serves as Chief Medical Officer and Chief Medical Director at Cruxpoint Health Breakthrough, Inc., where he leads science-based medical protocols focused on improving cardiometabolic and kidney health through integrated, data-driven approaches. His clinical work centers on comprehensive kidney care including inpatient dialysis oversight, preventive cardiometabolic risk reduction, and noninvasive cardiovascular risk assessment through advanced imaging and early-detection strategies. Dr. Ehrlich’s research interests include vascular calcification and mineral metabolism in kidney health, cardiovascular CT imaging and quantitative risk phenotyping, and evidence-based nutraceutical approaches to lipid and metabolic optimization. Among his professional achievements, Dr. Ehrlich received the “Ambassador of Bergamotto” Research Award for clinical contributions in cardiometabolic and hepatic health, co-founded the Society of Cardiovascular Computed Tomography, and is a founding member of the Society of Atherosclerosis Imaging. He has also held academic appointments as a Clinical Associate Professor of Medicine at the University of Colorado Health Sciences Center (Anschutz Medical Campus) and as an Adjunct Assistant Professor of Medicine at George Washington University Medical Center, and has provided leadership as a founder and former Medical Director of Colorado Heart and Body Imaging and as founder of Early Detection Technologies, LLC. He earned his MD from Rosalind Franklin University of Medicine and Science (Chicago Medical School).
Chief Medial Officer
Medical School
1972 – 1976
Residency
1976 – 1980